MW 429.9 Da, Purity >98%. Potent EGFR tyrosine kinase inhibitor (IC = 2 nM). Decreases EGFR autophosphorylation in tumor cells. Potent inhibitor of mutant JAK2-V617F. Weaker inhibitor of ErbB-2 kinase (Ki = 1 M) and ErbB-4 kinase (Ki = 1.5 M). Clinically effective agent for non-small cell lung cancer (NSCLC).
The product is subject to the following: Abcam Restricted Use Statement